Drug Information

Drug General Information
Drug ID
D02BZV
Former ID
DNC007745
Drug Name
BMS-1
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529859]
Structure
Download
2D MOL

3D MOL
Formula
C29H30FN3O2
Canonical SMILES
CC1=NC(=C(N1CCCCCCNC(=O)OC2=CC=CC=C2F)C3=CC=CC=C3)C4=CC<br />=CC=C4
InChI
1S/C29H30FN3O2/c1-22-32-27(23-14-6-4-7-15-23)28(24-16-8-5-9-17-24)33(22)21-13-3-2-12-20-31-29(34)35-26-19-11-10-18-25(26)30/h4-11,14-19H,2-3,12-13,20-21H2,1H3,(H,31,34)
InChIKey
LHAHTHILLRCRBM-UHFFFAOYSA-N
PubChem Compound ID
9956414
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529859]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529859J Med Chem. 2009 Jan 8;52(1):170-80.Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
Ref 529859J Med Chem. 2009 Jan 8;52(1):170-80.Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.